معرفی
Dr David Corcoran is an Honorary Clinical Lecturer at the University of Glasgow, affiliated with the School of Cardiovascular & Metabolic Health. His research focuses on coronary artery disease, post-COVID-19 cardiovascular outcomes, and cardiac imaging techniques. He has contributed to major trials like CorMicA, investigating coronary physiology and microvascular dysfunction. Dr. Corcoran’s work spans clinical trials (e.g., serelaxin’s vascular effects), post-pandemic health trajectories, and diagnostic innovations (e.g., automated myocardial blood flow analysis via MRI). He has published widely on angina management, myocardial infarction mechanisms, and multisystem post-viral complications. His research integrates imaging (CMR, MRI) with clinical practice to improve cardiovascular diagnostics and therapies.
- Research Interests: Coronary Microvascular Dysfunction, Post-COVID-19 Cardiovascular Effects, Cardiac Imaging, Fractional Flow Reserve (FFR), and Clinical Trial Design.
- Key Projects: CorMicA trial (coronary physiology stratification), CISCO-19 imaging study (COVID-19 cardiopulmonary effects), and CABG-ACS trials (invasive/non-invasive management).
- Publications: Over 50 peer-reviewed articles, emphasizing clinical trials, diagnostic advancements, and pandemic-related cardiovascular sequelae.